Sort
48,018 grants matching “immunotherapy”
3-D spatial approach to discover genomic effectors of immunosuppression during malignant transformation
$466,372Joseph F Costello · University Of California, San Francisco · R01 · FY2020 · CA
Vascular image-guided optimization of response (VIGOR) to therapy in kidney cancer
$466,346Ralph P Mason · Ut Southwestern Medical Center · R01 · FY2022 · CA
Local immune modulation for beta cell replacement therapy in type 1 diabetes
$466,338Edward Phelps · University Of Florida · R01 · FY2024 · DK
Mathematical modeling and molecular imaging to maximize response while minimizing toxicities from systemic therapies in preclinical models of breast cancer
$466,308Anna C Sorace · University Of Alabama At Birmingham · R01 · FY2025 · CA
Immunologic basis of phenotypic heterogeneity in peanut allergy
$466,249Maria Cecilia Berin · Icahn School Of Medicine At Mount Sinai · U19 · FY2019 · AI
The role of IL-10 in stabilizing natural regulatory T cells
$466,235Mitchell Kronenberg · La Jolla Institute For Immunology · P01 · FY2014 · AI
The role of IL-10 in stabilizing natural regulatory T cells
$466,235Mitchell Kronenberg · La Jolla Institute For Immunology · P01 · FY2012 · AI
PROOF-OF-CONCEPT STUDIES FOR A NOVEL IMMUNOTHERAPY FOR TRIPLE-NEGATIVE BREAST CANCER AND COMPANION DIAGNOSTIC
$466,234The University Of Queensland · · FY2025 · Defense Health Agency
Impact of tuberculosis on the development and function of the immune system in SIV-infected infants
$466,181Xiaolei Wang · Tulane University Of Louisiana · R01 · FY2021 · HD
MRI of tumor-infiltrating lymphocytes using MRI-cytometry
$466,131Junzhong Xu · Vanderbilt University Medical Center · R01 · FY2022 · CA
Tau Pathology and Calcium Dyshomeostasis: Novel Imaging Approach and Therapy
$466,125Einar M Sigurdsson · New York University School Of Medicine · R21 · FY2020 · AG
Passive and Active Immunization for Pneumocystis
$466,112Francis Gigliotti · University Of Rochester · R01 · FY2019 · AI
Passive and Active Immunization for Pneumocystis
$466,112Francis Gigliotti · University Of Rochester · R01 · FY2020 · AI
Passive and Active Immunization for Pneumocystis
$466,112Francis Gigliotti · University Of Rochester · R01 · FY2018 · AI
In Vivo Analysis of T lymphocytes in the Persistently Infected CNS
$466,000Dorian B McGavern · Scripps Research Institute, The · R01 · FY2007 · AI
Co-targeting BET Bromodomain Proteins and MNK Kinases in Pancreatic Cancer
$465,989Hidayatullah G Munshi · Northwestern University At Chicago · R01 · FY2024 · CA
Remodeling of Lymph Node-Derived Cytokine Responses at the Infected Tissue Site
$465,973Deborah J Fowell · Cornell University · R37 · FY2024 · AI
Remodeling of Lymph Node-Derived Cytokine Responses at the Infected Tissue Site
$465,973Deborah J Fowell · Cornell University · R37 · FY2025 · AI
T Cell Immunity in Endemic Burkitt Lymphoma
$465,952Ann M Moormann · Univ Of Massachusetts Med Sch Worcester · R01 · FY2010 · CA
Project 3 - Zuniga
$465,911Elina I Zuniga · University Of California, San Diego · P01 · FY2019 · AI
Studies of Inherited Causes of Fungal Susceptability
$465,906Sergio Rosenzweig · National Institute Of Allergy And Infectious Diseases · ZIA · FY2015 · AI
Fecal Microbiota Transplant and PD-1 blockade in Melanoma
$465,896Hassane M Zarour · University Of Pittsburgh At Pittsburgh · R01 · FY2019 · CA
Identifying Therapeutic Targets for Stage III Melanoma
$465,890Anand K Ganesan · University Of California-Irvine · R01 · FY2021 · CA
Threshold, Severity, and Immunotherapy of Peanut Allergy
$465,864Supinda Bunyavanich · Icahn School Of Medicine At Mount Sinai · U19 · FY2023 · AI
Targeting HSP70 for MelanomaTherapy
$465,781Maureen E Murphy · Wistar Institute · P01 · FY2021 · CA